These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 14699401)

  • 1. ComPPARtmentalizing NF-kappaB in the gut.
    Beg AA
    Nat Immunol; 2004 Jan; 5(1):14-6. PubMed ID: 14699401
    [No Abstract]   [Full Text] [Related]  

  • 2. Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA.
    Kelly D; Campbell JI; King TP; Grant G; Jansson EA; Coutts AG; Pettersson S; Conway S
    Nat Immunol; 2004 Jan; 5(1):104-12. PubMed ID: 14691478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide YY attenuates transcription factor activity in tumor necrosis factor-alpha-induced pancreatitis.
    Vona-Davis L; Yu A; Magabo K; Evans T; Jackson B; Riggs D; McFadden D
    J Am Coll Surg; 2004 Jul; 199(1):87-95. PubMed ID: 15217635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myocardial fibrosis and diastolic dysfunction in deoxycorticosterone acetate-salt hypertensive rats is ameliorated by the peroxisome proliferator-activated receptor-alpha activator fenofibrate, partly by suppressing inflammatory responses associated with the nuclear factor-kappa-B pathway.
    Ogata T; Miyauchi T; Sakai S; Takanashi M; Irukayama-Tomobe Y; Yamaguchi I
    J Am Coll Cardiol; 2004 Apr; 43(8):1481-8. PubMed ID: 15093887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipopolysaccharide from Salmonella enterica activates NF-kappaB through both classical and alternative pathways in primary B Lymphocytes.
    Souvannavong V; Saidji N; Chaby R
    Infect Immun; 2007 Oct; 75(10):4998-5003. PubMed ID: 17698569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diverse regulation of NF-kappaB and peroxisome proliferator-activated receptors in murine nonalcoholic fatty liver.
    Romics L; Kodys K; Dolganiuc A; Graham L; Velayudham A; Mandrekar P; Szabo G
    Hepatology; 2004 Aug; 40(2):376-85. PubMed ID: 15368442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interplay between the NF-kappaB and forkhead transcription factors.
    Peng SL
    Cell Death Differ; 2005 Jul; 12(7):699-701. PubMed ID: 15861187
    [No Abstract]   [Full Text] [Related]  

  • 8. The gut bacterium and pathobiont Bacteroides vulgatus activates NF-κB in a human gut epithelial cell line in a strain and growth phase dependent manner.
    Ó Cuív P; de Wouters T; Giri R; Mondot S; Smith WJ; Blottière HM; Begun J; Morrison M
    Anaerobe; 2017 Oct; 47():209-217. PubMed ID: 28583864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-talk between nuclear receptors and nuclear factor kappaB.
    De Bosscher K; Vanden Berghe W; Haegeman G
    Oncogene; 2006 Oct; 25(51):6868-86. PubMed ID: 17072333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut microbiology: fitting into the intestinal neighbourhood.
    Willing BP; Finlay BB
    Curr Biol; 2009 Jun; 19(11):R457-9. PubMed ID: 19515354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Negative cross-talk between the human orphan nuclear receptor Nur77/NAK-1/TR3 and nuclear factor-kappaB.
    Harant H; Lindley IJ
    Nucleic Acids Res; 2004; 32(17):5280-90. PubMed ID: 15466594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epithelial NF-kappaB maintains host gut microflora homeostasis.
    Ben-Neriah Y; Schmidt-Supprian M
    Nat Immunol; 2007 May; 8(5):479-81. PubMed ID: 17440457
    [No Abstract]   [Full Text] [Related]  

  • 13. Signaling events leading to the curative effect of cystatin on experimental visceral leishmaniasis: involvement of ERK1/2, NF-kappaB and JAK/STAT pathways.
    Kar S; Ukil A; Das PK
    Eur J Immunol; 2009 Mar; 39(3):741-51. PubMed ID: 19197936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TLR signalling and activation of IRFs: revisiting old friends from the NF-kappaB pathway.
    Moynagh PN
    Trends Immunol; 2005 Sep; 26(9):469-76. PubMed ID: 16006187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The intestinal epithelial barrier: how to distinguish between the microbial flora and pathogens.
    Magalhaes JG; Tattoli I; Girardin SE
    Semin Immunol; 2007 Apr; 19(2):106-15. PubMed ID: 17324587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NF-kappa B synergizes with NF-AT and NF-IL6 in activation of the IL-4 gene in T cells.
    Li-Weber M; Giaisi M; Baumann S; Pálfi K; Krammer PH
    Eur J Immunol; 2004 Apr; 34(4):1111-8. PubMed ID: 15048722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The LIM-homeodomain transcription factor LMX1B regulates expression of NF-kappa B target genes.
    Rascle A; Neumann T; Raschta AS; Neumann A; Heining E; Kastner J; Witzgall R
    Exp Cell Res; 2009 Jan; 315(1):76-96. PubMed ID: 18996370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of novel mediators of NF-kappaB through genome-wide survey of monocyte adherence-induced genes.
    Diatchenko L; Romanov S; Malinina I; Clarke J; Tchivilev I; Li X; Makarov SS
    J Leukoc Biol; 2005 Dec; 78(6):1366-77. PubMed ID: 16204640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A biophysical characterisation of factors controlling dimerisation and selectivity in the NF-kappaB and NFAT families.
    de Lumley M; Hart DJ; Cooper MA; Symeonides S; Blackburn JM
    J Mol Biol; 2004 Jun; 339(5):1059-75. PubMed ID: 15178248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adipocyte differentiation induces dynamic changes in NF-kappaB expression and activity.
    Berg AH; Lin Y; Lisanti MP; Scherer PE
    Am J Physiol Endocrinol Metab; 2004 Dec; 287(6):E1178-88. PubMed ID: 15251865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.